SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 128,300
-700 (-0.54%)
At close: Dec 19, 2025
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 10.09 trillion as of December 19, 2025. Its market cap has increased by 32.07% in one year.
Market Cap
10.09T
Enterprise Value
9.90T
Revenue
675.41B
Ranking
n/a
PE Ratio
31.50
Stock Price
128,300.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has increased from 9.95T to 10.09T, an increase of 1.50%. That is a compound annual growth rate of 0.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 10.10T | 16.11% |
| Dec 30, 2024 | 8.70T | 10.66% |
| Dec 28, 2023 | 7.86T | 39.25% |
| Dec 29, 2022 | 5.65T | -25.82% |
| Dec 30, 2021 | 7.61T | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.45T |
| Celltrion | 39.84T |
| ALTEOGEN | 23.05T |
| ABL Bio | 10.29T |
| Yuhan | 8.52T |
| LigaChem Biosciences | 6.08T |
| HLB Co., Ltd. | 6.05T |
| Peptron | 5.58T |